Status:
UNKNOWN
Precision Medicine for Colorectal Cancer Liver Metastasis Guided by Multi-omics Data Under the Umbrella Theory
Lead Sponsor:
Fudan University
Conditions:
Colorectal Cancer Metastatic
Eligibility:
All Genders
18-70 years
Brief Summary
In order to more accurately discover the cause of drug resistance in tumor treatment, and to provide a new basis for precise treatment. Therefore, based on the umbrella theory of precision medicine, ...
Eligibility Criteria
Inclusion
- ECOG score 0-2 points
- Pathologically diagnosed patients with colorectal cancer
- Combined with liver metastases confirmed by imaging, and the lesion is measurable (RECIST standard)
- The lesion is available
- First-line treatment failed; hematology, liver and kidney function tests are suitable for back-line treatment
- Informed consent
Exclusion
- With brain metastases
- History of other malignancies
- Pregnancy or breastfeeding
- Have received other drug clinical studies within 30 days before the start of this study
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04525807
Start Date
September 1 2020
End Date
September 1 2022
Last Update
August 25 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.